Herpetic whitlow is a viral infection of the distal phalanx caused by herpes simplex virus (HSV-1 or HSV-2), acquired through direct inoculation into broken skin. It is self-limiting (14–21 days), and the critical clinical pearl is to avoid incision and drainage, which can worsen the infection and cause secondary bacterial superinfection. [1-3]
1. History
- Mechanism of inoculation: Ask about thumb/finger sucking (children), nail biting, contact with oral/genital herpes lesions, or occupational exposure (healthcare workers, dental professionals) [4-5]
- Prodrome: Tingling, burning, or pain at the affected digit up to 72 hours before vesicle formation [4]
- Symptom characterization: Painful swelling, erythema, and grouped vesicles on the distal phalanx; vesicles may coalesce into a "honeycomb" appearance with scant, non-purulent or serosanguinous fluid [2-3]
- Timing: Primary infection lasts 14–21 days in immunocompetent patients (up to 21–28 days in healthcare workers with HSV-1) [3-4]
- Recurrence history: HSV-2 whitlow recurs more frequently than HSV-1; ask about prior episodes and frequency [4]
- Important negatives: Absence of frank purulence (distinguishes from bacterial felon), no history of penetrating trauma or bite wound
2. Alarm Features
- Lymphangitis and lymphadenopathy — may indicate significant primary infection or secondary bacterial superinfection [4]
- Rapidly spreading erythema or cellulitis — consider bacterial superinfection
- Immunocompromised host — risk of disseminated HSV, chronic non-healing ulcers, and acyclovir-resistant strains [1]
- Fever, systemic toxicity — atypical for uncomplicated whitlow; consider secondary infection or dissemination
- Concern for pyogenic flexor tenosynovitis — Kanavel signs (fusiform swelling, flexed posture, tenderness along sheath, pain with passive extension) require urgent surgical consultation [6-7]
3. Medications
- Antiviral therapy (most effective when initiated during prodrome or within 48–72 hours of onset):
- Valacyclovir 1 g PO BID × 7–10 days (primary) or 500 mg PO BID × 5 days (recurrent) [8-9]
- Acyclovir 400 mg PO 5 times/day × 7–10 days (primary) or 200 mg PO 5 times/day × 5 days (recurrent) [9-10]
- Famciclovir 250 mg PO TID × 7–10 days (primary) [9]
- For frequent recurrences: acyclovir 800 mg PO BID initiated during prodrome may abort attacks [4]
- Suppressive therapy for ≥6 recurrences/year: acyclovir 400 mg PO BID or valacyclovir 500 mg–1 g PO daily [8-9]
- Renal dose adjustment required for all antivirals [8]
- Contraindicated: Incision and drainage — this is an aseptic process and surgical intervention can introduce bacterial infection and worsen outcomes [1][3][5]
- Avoid unnecessary antibiotics unless bacterial superinfection is documented
4. Diet
- No specific dietary triggers or restrictions
- Adequate hydration is recommended during antiviral therapy (acyclovir is renally cleared and can cause crystalline nephropathy with dehydration) [8]
5. Review of Systems
- Constitutional: Fever, malaise (more common in primary infection)
- HEENT: Oral lesions (gingivostomatitis — source of autoinoculation, especially in children) [5]
- Genitourinary: Genital herpes lesions (source of HSV-2 inoculation) [4]
- Neurologic: Paresthesias in the affected digit
- Lymphatic: Ipsilateral epitrochlear or axillary lymphadenopathy
- Skin: Other vesicular lesions elsewhere on the body (dissemination concern in immunocompromised)
6. Collateral History and Family History
- Household contacts with active oral or genital herpes — person-to-person transmission documented, especially to children [5]
- Occupational history: Healthcare workers (dentists, nurses, respiratory therapists) historically at high risk before universal glove use [4]
- Child with whitlow: Investigate for possible sexual abuse if no clear autoinoculation source, though most pediatric cases are from oral HSV-1 autoinoculation [5]
7. Risk Factors
- Thumb/finger sucking or nail biting in children with concurrent herpetic gingivostomatitis [2][5]
- Healthcare workers exposed to oral secretions [4]
- Active oral or genital herpes with autoinoculation via broken skin
- Immunocompromised states (HIV, transplant, chemotherapy) — increased severity, chronicity, and risk of acyclovir resistance [1]
- Eczema or other dermatitis disrupting skin barrier
8. Differential Diagnosis
- Bacterial felon — tense, fluctuant pulp space abscess with frank purulence; 65% of pediatric herpetic whitlow cases are initially misdiagnosed as bacterial felon. Felon has a single tense collection vs. grouped vesicles [5]
- Acute paronychia — infection of the nail fold, typically with purulent drainage; may coexist [11-12]
- Bacterial cellulitis — diffuse erythema without discrete vesicles [2]
- Contact dermatitis — pruritic rather than painful; no grouped vesicles on an erythematous base
- Pyogenic flexor tenosynovitis — Kanavel signs; surgical emergency [6]
- Embolic phenomena (Osler nodes, Janeway lesions) — consider in patients with risk factors for endocarditis [2]
- Blistering dactylitis (streptococcal) — superficial blister on the volar fat pad, more common in children
9. Past Medical History
- Prior HSV infections (oral, genital, or digital) and recurrence frequency
- Immunocompromising conditions (HIV status, transplant, malignancy, immunosuppressive medications)
- Atopic dermatitis or eczema (risk for eczema herpeticum if widespread)
- Prior surgical drainage of the digit (may indicate prior misdiagnosis)
10. Physical Exam
- Inspection: Grouped vesicles on an erythematous base, typically on the volar aspect of the distal phalanx; vesicles may coalesce with a "honeycomb" appearance; fluid is clear to serosanguinous (not frankly purulent) [2-3]
- Palpation: Tender but not tense/fluctuant as in a felon; swelling of the distal digit
- Lymphatic exam: Ipsilateral epitrochlear and axillary lymphadenopathy; lymphangitic streaking may be present [4]
- Kanavel signs: Assess to rule out flexor tenosynovitis (fusiform swelling, flexed posture, tenderness along tendon sheath, pain with passive extension)
- Nail exam: Subungual or periungual vesicles may be present
11. Lab Studies
- Routine labs are generally unnecessary for uncomplicated cases
- HSV NAAT (PCR) from unroofed vesicle base — most sensitive and specific test (sensitivity 96.7–100%); can distinguish HSV-1 from HSV-2 [13-14]
- Viral culture — sensitivity 30–70%, useful if antiviral susceptibility testing is needed [13-14]
- Tzanck smear — rapid but low sensitivity; shows multinucleated giant cells (non-specific for HSV vs. VZV)
- Serology — not useful for acute diagnosis; IgG indicates prior exposure, not active infection; IgM is unreliable [13]
- If bacterial superinfection suspected: wound culture, CBC, CRP
12. Imaging
- Imaging is generally unnecessary for uncomplicated herpetic whitlow
- X-ray of the digit may be considered if concern for osteomyelitis (chronic/recurrent cases) or to rule out foreign body in traumatic inoculation
- No role for CT or MRI in typical presentations
13. Special Tests
- Unroofing vesicles for specimen collection: vigorously swab the base of the lesion with a viral culture transport swab [13]
- Direct fluorescent antibody (DFA) testing — less sensitive than NAAT but provides rapid results [13]
- Point-of-care: Clinical diagnosis is often sufficient in classic presentations; confirmatory testing is recommended when the diagnosis is uncertain or in immunocompromised patients
14. ECG
15. Assessment
Herpetic whitlow is a self-limiting HSV infection of the digit that resolves in 14–21 days without treatment. The most important clinical consideration is distinguishing it from a bacterial felon or paronychia to avoid unnecessary and potentially harmful surgical intervention. [3][5] Primary infections tend to be more severe and prolonged (especially in healthcare workers), while recurrences are shorter but may be frequent with HSV-2. [4] Complications include secondary bacterial superinfection, lymphangitis, and in immunocompromised patients, chronic ulceration or dissemination. [1]
16. Treatment Plan
- Conservative management is the cornerstone: elevation, dry dressing, and pain control [6]
- Oral antivirals initiated early (ideally during prodrome) may hasten healing and reduce viral shedding: [10][15]
- Valacyclovir 1 g PO BID × 7–10 days (primary) — preferred for dosing convenience [8]
- Acyclovir 400 mg PO 5 times/day × 7–10 days (primary) [9]
- Recurrent episodes: shorter courses (5 days) [9]
- Pain management: NSAIDs, acetaminophen; consider nerve block for severe pain
- Wound care: Keep dry, cover with a non-adherent dressing to prevent autoinoculation and transmission
- Do NOT incise and drain — this is a critical teaching point [1][3][5]
- Immunocompromised patients: Consider IV acyclovir 5 mg/kg q8h for severe cases; monitor for acyclovir-resistant strains (treat with IV foscarnet) [1][16]
- Suppressive therapy for frequent recurrences (≥6/year): valacyclovir 500 mg–1 g PO daily or acyclovir 400 mg PO BID [8]
17. Disposition
- Discharge — the vast majority of cases are managed outpatient [6]
- Admission criteria: Immunocompromised with severe/disseminated infection, suspected secondary bacterial infection requiring IV antibiotics, or concern for pyogenic flexor tenosynovitis
- Surgical consultation: Only if bacterial abscess is confirmed or flexor tenosynovitis is suspected; surgery is contraindicated for the herpetic whitlow itself [1][7]
- Infectious disease consultation: Immunocompromised patients, suspected acyclovir resistance
18. Follow Up / Return Precautions
- Follow-up in 7–10 days if not improving, or sooner if worsening
- Return precautions: Increasing pain, spreading redness, purulent drainage (suggests bacterial superinfection), fever, or red streaking up the arm
- Patient counseling:
- Condition is contagious — avoid direct skin contact with others, especially neonates and immunocompromised individuals
- Healthcare workers should not perform direct patient care until lesions are fully crusted/healed [4]
- Recurrences are common (23% in pediatric cases, higher with HSV-2) and may be triggered by stress, illness, or UV exposure [5]
- Expected course: vesicles crust over in 7–10 days, full resolution in 2–3 weeks
- Initiate antivirals at the first sign of prodromal symptoms in recurrent episodes to shorten duration [4]
References
1. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
2. An Unusual Pediatric Manifestation of the Herpes Simplex Virus. — Salerno N, Doolan JJ. Journal of the American Podiatric Medical Association. 2022.
3. The Treatment of Herpetic Whitlow--a New Surgical Concept. — Polayes IM, Arons MS. Plastic and Reconstructive Surgery. 1980.
4. Herpes Simplex Virus Infection of the Hand. Clinical Features and Management. — Gill MJ, Arlette J, Tyrrell DL, Buchan KA. The American Journal of Medicine. 1988.
5. Multiple Herpetic Whitlow Lesions in a 4-Year-Old Girl: Case Report and Review of the Literature. — Szinnai G, Schaad UB, Heininger U. European Journal of Pediatrics. 2001.
6. Acute Hand Infections. — Rerucha CM, Ewing JT, Oppenlander KE, Cowan WC. American Family Physician. 2019.
7. Hand Infections. — Franko OI, Abrams RA. The Orthopedic Clinics of North America. 2013.
8. FDA Drug Label. — Updated date: 2026-02-16. Food and Drug Administration.
9. Herpes Simplex Virus Infections. — Whitley RJ, Roizman B. Lancet. 2001.
10. Treatment of Mucocutaneous Herpes Simplex Infections With Acyclovir. — Krusinski PA. Journal of the American Academy of Dermatology. 1988.
11. Management of Finger Felons and Paronychia: A Narrative Review. — Gottlieb M, Long B. The Journal of Emergency Medicine. 2025.
12. Acute and Chronic Paronychia. — Leggit JC. American Family Physician. 2017.
13. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). — Miller JM, Binnicker MJ, Campbell S, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2024.
14. Diagnosis and Treatment of Sexually Transmitted Infections: A Review. — Tuddenham S, Hamill MM, Ghanem KG. The Journal of the American Medical Association. 2022.
15. Common Acute Hand Infections. — Clark DC. American Family Physician. 2003.
16. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV. — Constance Benson, John Brooks, Shireesha Dhanireddy, et al Infectious Diseases Society of America; Office of AIDS Research Advisory Council (2025). 2025.